ストックスクリーナーアプリを入手
90.67
0.95%
0.81
Astrazeneca PLC (AZN) 最新ニュース
[XMAS PERIOD] LSEG, Rolls-Royce, AstraZeneca and Rightmove spotlighted as investment bank eyes potential winners for 2026 - Proactive Investors
Daiichi Sankyo, AstraZeneca apply for second EU approval for Datroway - marketscreener.com
Texas Permanent School Fund Corp Has $4.94 Million Holdings in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca Pharma India wins CDSCO permission to import breast cancer drug Datverzo - Medical Dialogues
Anastrozole Tablets Market is Thriving Worldwide | AstraZeneca - openPR.com
Assenagon Asset Management S.A. Sells 569,162 Shares of AstraZeneca PLC $AZN - MarketBeat
Rep. Gilbert Ray Cisneros, Jr. Buys AstraZeneca PLC (NASDAQ:AZN) Stock - MarketBeat
Compugen stock soars on $65 million AstraZeneca royalty deal By Investing.com - Investing.com Nigeria
AstraZeneca stock: positive regulatory news and strong technical base drive 1.17% advance - Traders Union
Compugen rises on royalty deal with AstraZeneca - MSN
Compugen rises on royalty deal with AstraZeneca (CGEN:NASDAQ) - Seeking Alpha
Compugen monetizes portion of cancer drug royalties to AstraZeneca By Investing.com - Investing.com South Africa
Sanders Morris Harris LLC Invests $950,000 in AstraZeneca PLC $AZN - MarketBeat
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million - marketscreener.com
AstraZeneca Partners with Lebanese Health Ministry on Lung Cancer Awareness - marketscreener.com
AstraZeneca Gets FDA Nod For Breast Cancer Drug, EU Clearance For Lupus Pen - Benzinga
AstraZeneca (AZN) Receives EU Approval for Saphnelo Self-Adminis - GuruFocus
AstraZeneca receives EU approval for subcutaneous Saphnelo self-administration By Investing.com - Investing.com South Africa
AstraZeneca PLCEnhertu approved in US for 1L HER2+ metastatic BC - Research Tree
AstraZeneca chalks up dual regulatory wins in cancer and immunology - Vox Markets
AstraZeneca PLC (NASDAQ:AZN) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
AstraZeneca update within FTSE 350 and FTSE 100 healthcare landscape - Kalkine Media
AstraZeneca and Daiichi Sankyo's Enhertu approved as first-line therapy for HER2+ breast cancer - marketscreener.com
AstraZeneca’s Saphnelo approved in EU for self-administration in lupus By Investing.com - Investing.com UK
AstraZeneca Receives EU Approval for Pre-filled Pen for Lupus - marketscreener.com
AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer - DirectorsTalk Interviews
AstraZeneca says subcutaneous Saphnelo approved in EU - marketscreener.com
REGAstraZeneca PLCSubcutaneous Saphnelo approved in EU - TradingView — Track All Markets
AstraZeneca, Daiichi Sankyo's Enhertu Regimen Greenlit as First-line Breast Cancer Treatment in US - marketscreener.com
AstraZeneca, Daiichi Sankyo's Enhertu Combination Gets US Approval for Breast Cancer Treatment - marketscreener.com
AstraZeneca Withdraws Andexxa, Unable To Find Path Forward With US FDA - Citeline News & Insights
Astrazeneca (AZN) Rises As Market Takes a Dip: Key Facts - Yahoo Finance
AstraZeneca PLC ADR Underperforms Monday When Compared To Competitors Despite Daily Gains - 富途牛牛
AstraZeneca (AZN) and Daiichi Sankyo's Enhertu Combo Gains FDA A - GuruFocus
AstraZeneca (AZN) Gains FDA Approval for Breast Cancer Treatment - GuruFocus
AstraZeneca's Enhertu and Genentech's Perjeta combo gains breast cancer approval - Seeking Alpha
AstraZeneca, Daiichi's breast cancer drug gets FDA nod as first-line treatment - Reuters
AstraZeneca and Daiichi Sankyo's enhertu gets US cancer approval - marketscreener.com
AstraZeneca (AZN) Gains FDA Approval for Enhertu in Breast Cance - GuruFocus
Geneos Wealth Management Inc. Grows Stock Holdings in AstraZeneca PLC $AZN - MarketBeat
How New Deals and Diverging Analyst Views Are Rewriting the Story for AstraZeneca - Yahoo Finance
Holocene Advisors LP Sells 124,752 Shares of AstraZeneca PLC $AZN - MarketBeat
Rexford Capital Inc. Invests $948,000 in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca Unveils Sweeping Blood Cancer Push With Record ASH Presence - MyChesCo
Why is AstraZeneca PLC (AZN) one of the best pharma stocks to invest in? - MSN
AstraZeneca PLC $AZN Shares Bought by Cubist Systematic Strategies LLC - MarketBeat
AstraZeneca PLC $AZN Shares Bought by BI Asset Management Fondsmaeglerselskab A S - MarketBeat
GSK Expands Use Of Urinary Tract Infection Drug For Gonorrhoea Patients - Benzinga
AstraZeneca (AZN) At the Center of Serious Analyst Attention - Insider Monkey
Parkwood LLC Buys 112,053 Shares of AstraZeneca PLC $AZN - MarketBeat
Federated Hermes Inc. Has $10.83 Million Stake in AstraZeneca PLC $AZN - MarketBeat
Swedish Stocks in North America – AstraZeneca Drops 0.8 Percent - marketscreener.com
AstraZeneca PLC ADR Falls Thursday, Underperforms Market - 富途牛牛
Details trickle in about salary, size at AstraZeneca's new Albemarle plant - Richmond Times-Dispatch
Is the Market Bullish or Bearish on AstraZeneca PLC? - Benzinga
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.01 Million Stake in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC ADR outperforms market on strong trading day - MarketWatch
Why is AstraZeneca PLC (AZN) One of the Best Pharma Stocks to Invest In? - Insider Monkey
AstraZeneca: A Rare Compound Growth Opportunity In Biopharma (AZN) - Seeking Alpha
60,378 Shares in AstraZeneca PLC $AZN Bought by Norges Bank - MarketBeat
Aug Ideas: Will Precidian ETFs Trust AstraZeneca PLC stock maintain strong growthJuly 2025 Sector Moves & Smart Allocation Stock Reports - moha.gov.vn
AstraZeneca price target raised to $105 from $95 at TD Cowen on growth outlook - Investing.com UK
AstraZeneca (AZN) Begins Phase 3 Trial of Enhertu for Ovarian Ca - GuruFocus
大文字化:
|
ボリューム (24 時間):